The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bilirubin Blood Test Market Research Report 2025
Synopsis
Bilirubin is a vital compound which possesses the capability of breaking down heme, an iron-containing compound. The abnormally high level of bilirubin signifies the presence of jaundice, anemia, and other liver diseases. The bilirubin blood tests can detect elevated levels of bilirubin in the blood and assist patient in taking appropriate measures.
The global Bilirubin Blood Test market was valued at US$ 1029.8 million in 2023 and is anticipated to reach US$ 1435.6 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bilirubin Blood Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bilirubin Blood Test.
Report Scope
The Bilirubin Blood Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bilirubin Blood Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bilirubin Blood Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Company
Philips
Drager
Konica Minolta
Natus Medical
Apel
Reichert Technologies
Mennen Medical
Advanced Instruments
GINEVRI
Lowenstein
AVI Healthcare
Qili Medical
Beijing M&B
DAS
Kejian Hi-tech
Micro Lab
Olidef
Dison
Segment by Type
Transcutaneous
Bench-top
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bilirubin Blood Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bilirubin is a vital compound which possesses the capability of breaking down heme, an iron-containing compound. The abnormally high level of bilirubin signifies the presence of jaundice, anemia, and other liver diseases. The bilirubin blood tests can detect elevated levels of bilirubin in the blood and assist patient in taking appropriate measures.
The global Bilirubin Blood Test market was valued at US$ 1029.8 million in 2023 and is anticipated to reach US$ 1435.6 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bilirubin Blood Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bilirubin Blood Test.
Report Scope
The Bilirubin Blood Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bilirubin Blood Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bilirubin Blood Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Company
Philips
Drager
Konica Minolta
Natus Medical
Apel
Reichert Technologies
Mennen Medical
Advanced Instruments
GINEVRI
Lowenstein
AVI Healthcare
Qili Medical
Beijing M&B
DAS
Kejian Hi-tech
Micro Lab
Olidef
Dison
Segment by Type
Transcutaneous
Bench-top
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bilirubin Blood Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bilirubin Blood Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Transcutaneous
1.2.3 Bench-top
1.3 Market by Application
1.3.1 Global Bilirubin Blood Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bilirubin Blood Test Market Perspective (2019-2030)
2.2 Bilirubin Blood Test Growth Trends by Region
2.2.1 Global Bilirubin Blood Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bilirubin Blood Test Historic Market Size by Region (2019-2024)
2.2.3 Bilirubin Blood Test Forecasted Market Size by Region (2025-2030)
2.3 Bilirubin Blood Test Market Dynamics
2.3.1 Bilirubin Blood Test Industry Trends
2.3.2 Bilirubin Blood Test Market Drivers
2.3.3 Bilirubin Blood Test Market Challenges
2.3.4 Bilirubin Blood Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bilirubin Blood Test Players by Revenue
3.1.1 Global Top Bilirubin Blood Test Players by Revenue (2019-2024)
3.1.2 Global Bilirubin Blood Test Revenue Market Share by Players (2019-2024)
3.2 Global Bilirubin Blood Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bilirubin Blood Test Revenue
3.4 Global Bilirubin Blood Test Market Concentration Ratio
3.4.1 Global Bilirubin Blood Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bilirubin Blood Test Revenue in 2023
3.5 Bilirubin Blood Test Key Players Head office and Area Served
3.6 Key Players Bilirubin Blood Test Product Solution and Service
3.7 Date of Enter into Bilirubin Blood Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bilirubin Blood Test Breakdown Data by Type
4.1 Global Bilirubin Blood Test Historic Market Size by Type (2019-2024)
4.2 Global Bilirubin Blood Test Forecasted Market Size by Type (2025-2030)
5 Bilirubin Blood Test Breakdown Data by Application
5.1 Global Bilirubin Blood Test Historic Market Size by Application (2019-2024)
5.2 Global Bilirubin Blood Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bilirubin Blood Test Market Size (2019-2030)
6.2 North America Bilirubin Blood Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bilirubin Blood Test Market Size by Country (2019-2024)
6.4 North America Bilirubin Blood Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bilirubin Blood Test Market Size (2019-2030)
7.2 Europe Bilirubin Blood Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bilirubin Blood Test Market Size by Country (2019-2024)
7.4 Europe Bilirubin Blood Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bilirubin Blood Test Market Size (2019-2030)
8.2 Asia-Pacific Bilirubin Blood Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bilirubin Blood Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Bilirubin Blood Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bilirubin Blood Test Market Size (2019-2030)
9.2 Latin America Bilirubin Blood Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bilirubin Blood Test Market Size by Country (2019-2024)
9.4 Latin America Bilirubin Blood Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bilirubin Blood Test Market Size (2019-2030)
10.2 Middle East & Africa Bilirubin Blood Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bilirubin Blood Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Bilirubin Blood Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Company
11.1.1 Company Company Detail
11.1.2 Company Business Overview
11.1.3 Company Bilirubin Blood Test Introduction
11.1.4 Company Revenue in Bilirubin Blood Test Business (2019-2024)
11.1.5 Company Recent Development
11.2 Philips
11.2.1 Philips Company Detail
11.2.2 Philips Business Overview
11.2.3 Philips Bilirubin Blood Test Introduction
11.2.4 Philips Revenue in Bilirubin Blood Test Business (2019-2024)
11.2.5 Philips Recent Development
11.3 Drager
11.3.1 Drager Company Detail
11.3.2 Drager Business Overview
11.3.3 Drager Bilirubin Blood Test Introduction
11.3.4 Drager Revenue in Bilirubin Blood Test Business (2019-2024)
11.3.5 Drager Recent Development
11.4 Konica Minolta
11.4.1 Konica Minolta Company Detail
11.4.2 Konica Minolta Business Overview
11.4.3 Konica Minolta Bilirubin Blood Test Introduction
11.4.4 Konica Minolta Revenue in Bilirubin Blood Test Business (2019-2024)
11.4.5 Konica Minolta Recent Development
11.5 Natus Medical
11.5.1 Natus Medical Company Detail
11.5.2 Natus Medical Business Overview
11.5.3 Natus Medical Bilirubin Blood Test Introduction
11.5.4 Natus Medical Revenue in Bilirubin Blood Test Business (2019-2024)
11.5.5 Natus Medical Recent Development
11.6 Apel
11.6.1 Apel Company Detail
11.6.2 Apel Business Overview
11.6.3 Apel Bilirubin Blood Test Introduction
11.6.4 Apel Revenue in Bilirubin Blood Test Business (2019-2024)
11.6.5 Apel Recent Development
11.7 Reichert Technologies
11.7.1 Reichert Technologies Company Detail
11.7.2 Reichert Technologies Business Overview
11.7.3 Reichert Technologies Bilirubin Blood Test Introduction
11.7.4 Reichert Technologies Revenue in Bilirubin Blood Test Business (2019-2024)
11.7.5 Reichert Technologies Recent Development
11.8 Mennen Medical
11.8.1 Mennen Medical Company Detail
11.8.2 Mennen Medical Business Overview
11.8.3 Mennen Medical Bilirubin Blood Test Introduction
11.8.4 Mennen Medical Revenue in Bilirubin Blood Test Business (2019-2024)
11.8.5 Mennen Medical Recent Development
11.9 Advanced Instruments
11.9.1 Advanced Instruments Company Detail
11.9.2 Advanced Instruments Business Overview
11.9.3 Advanced Instruments Bilirubin Blood Test Introduction
11.9.4 Advanced Instruments Revenue in Bilirubin Blood Test Business (2019-2024)
11.9.5 Advanced Instruments Recent Development
11.10 GINEVRI
11.10.1 GINEVRI Company Detail
11.10.2 GINEVRI Business Overview
11.10.3 GINEVRI Bilirubin Blood Test Introduction
11.10.4 GINEVRI Revenue in Bilirubin Blood Test Business (2019-2024)
11.10.5 GINEVRI Recent Development
11.11 Lowenstein
11.11.1 Lowenstein Company Detail
11.11.2 Lowenstein Business Overview
11.11.3 Lowenstein Bilirubin Blood Test Introduction
11.11.4 Lowenstein Revenue in Bilirubin Blood Test Business (2019-2024)
11.11.5 Lowenstein Recent Development
11.12 AVI Healthcare
11.12.1 AVI Healthcare Company Detail
11.12.2 AVI Healthcare Business Overview
11.12.3 AVI Healthcare Bilirubin Blood Test Introduction
11.12.4 AVI Healthcare Revenue in Bilirubin Blood Test Business (2019-2024)
11.12.5 AVI Healthcare Recent Development
11.13 Qili Medical
11.13.1 Qili Medical Company Detail
11.13.2 Qili Medical Business Overview
11.13.3 Qili Medical Bilirubin Blood Test Introduction
11.13.4 Qili Medical Revenue in Bilirubin Blood Test Business (2019-2024)
11.13.5 Qili Medical Recent Development
11.14 Beijing M&B
11.14.1 Beijing M&B Company Detail
11.14.2 Beijing M&B Business Overview
11.14.3 Beijing M&B Bilirubin Blood Test Introduction
11.14.4 Beijing M&B Revenue in Bilirubin Blood Test Business (2019-2024)
11.14.5 Beijing M&B Recent Development
11.15 DAS
11.15.1 DAS Company Detail
11.15.2 DAS Business Overview
11.15.3 DAS Bilirubin Blood Test Introduction
11.15.4 DAS Revenue in Bilirubin Blood Test Business (2019-2024)
11.15.5 DAS Recent Development
11.16 Kejian Hi-tech
11.16.1 Kejian Hi-tech Company Detail
11.16.2 Kejian Hi-tech Business Overview
11.16.3 Kejian Hi-tech Bilirubin Blood Test Introduction
11.16.4 Kejian Hi-tech Revenue in Bilirubin Blood Test Business (2019-2024)
11.16.5 Kejian Hi-tech Recent Development
11.17 Micro Lab
11.17.1 Micro Lab Company Detail
11.17.2 Micro Lab Business Overview
11.17.3 Micro Lab Bilirubin Blood Test Introduction
11.17.4 Micro Lab Revenue in Bilirubin Blood Test Business (2019-2024)
11.17.5 Micro Lab Recent Development
11.18 Olidef
11.18.1 Olidef Company Detail
11.18.2 Olidef Business Overview
11.18.3 Olidef Bilirubin Blood Test Introduction
11.18.4 Olidef Revenue in Bilirubin Blood Test Business (2019-2024)
11.18.5 Olidef Recent Development
11.19 Dison
11.19.1 Dison Company Detail
11.19.2 Dison Business Overview
11.19.3 Dison Bilirubin Blood Test Introduction
11.19.4 Dison Revenue in Bilirubin Blood Test Business (2019-2024)
11.19.5 Dison Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
